1164 (1164) Fair Value & Analysis

Energy · Market cap HK$18.5B

1 1164 1164 · HK

PriceHK$2.44

Fair ValueHK$1.01

Upside-58.6%

Quality42/100

Evidence: High Range HK$0.7600 – HK$1.27

Fair value as of: Jul 2, 2026

From 15 valuation models · updated today

Share price −23.6% over the past month.

Price vs Fair Value (12 months)

12‑month range HK$2.01 – HK$5.23 · fair‑value band HK$0.7600 – HK$1.27 · the HK$2.44 price screens above the HK$1.01 fair value. As of Jul 2, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

1164 (1164) currently trades at HK$2.44, while our model-based Fair Value estimate is HK$1.01 — implying the stock looks roughly 58.6% overvalued today. We read business quality at 42/100 (below-average quality), in the Energy sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).

Over the trailing twelve months, 1164 generated revenue of HK$6.9B at a net margin of 6.6%. Revenue declined 58.0% year over year. It earns a return on equity of 10.7%. Net debt stands at HK$2.1B. Fundamentals as of Jul 2, 2026

Key figures & financial health

Revenue (TTM) HK$6.9B

Revenue growth (YoY) -58.0%

Net margin 6.6%

Return on equity 10.7%

Free cash flow −HK$985M FY2025

P/E ratio 40.7

More key figures

Operating margin 5.3%

EPS (TTM) HK$-0.0100

Dividend yield 0.6%

EPS growth (YoY) -36.9%

Net debt HK$2.1B FY2025

Figures from reported company fundamentals (EODHD) · as of Jul 2, 2026. TTM = trailing twelve months.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

1164 reported revenue of HK$6.9B in FY2025 versus HK$3.9B in FY2021, a compound +15.5%/yr. Reported net income was HK$453M in FY2025, compounding +26.2%/yr from FY2021.

Revenue +15.5%/yr

FY21 HK$3.9B

FY22 HK$3.6B

FY23 HK$7.4B

FY24 HK$8.6B

FY25 HK$6.9B

Net income +26.2%/yr

FY21 HK$178M

FY22 HK$515M

FY23 HK$497M

FY24 HK$342M

FY25 HK$453M

Is 1164 fairly valued? → Check now

Similar stocks

6 more Uranium stocks, each showing price versus our Fair Value estimate (as of Jul 2, 2026).

Stock	Price	Fair Value	vs Fair Value
National Atomic Company KAP	$0.6900	$0.0100	-99%
Cameco Corporation CCJ	$107.07	$14.41	-87%
China National Uranium Co 001280	¥67.82	¥11.54	-83%
NexGen Energy Ltd NXE	$9.27	$3.56	-62%
NXG NXG	A$14.03	A$5.10	-64%
Uranium Energy Corp UEC	$11.47	$3.61	-69%

Explore undervalued stocks

More undervalued Energy stocks →

All undervalued stocks Technology Financial Services Healthcare Consumer Cyclical Consumer Defensive Communication Services Industrials Energy Basic Materials Real Estate Utilities Deeply Undervalued Stocks Undervalued Blue-Chip Stocks Undervalued Small-Cap Stocks

Frequently asked questions

Is 1164 (1164) undervalued?

As of Jul 2, 2026, our model estimates a fair value of HK$1.01 versus a price of HK$2.44 — about −59% (overvalued). Model-based estimate, not financial advice.

What is the fair value of 1164?

Our model-based fair value for 1164 is HK$1.01 (as of Jul 2, 2026), built from audited fundamentals. The current price is HK$2.44.

What is the quality score of 1164?

1164 has a Quality Score of 42/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

What is the revenue of 1164 (1164)?

1164 reported trailing-twelve-month revenue of about HK$6.9B (latest available figure, as of Jul 2, 2026).

What is the net profit margin of 1164?

The net profit margin of 1164 is about 6.6%, meaning it keeps roughly 6.6% of revenue as net income. Based on the latest reported figures.

Does 1164 pay a dividend?

1164 currently shows a dividend yield of about 0.56% relative to its recent price (as of Jul 2, 2026).

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.